Sandostatin LAR

octreotide · Novartis

Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for Sandostatin LAR, covering 2008-04-07 to 2026-04-28. Get the full timeline:

Most recent: Clinical Trial Update: Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas [Phase 2, Phase 3]

See pricing